Literature DB >> 24971402

In the sandbox: palliative care and hematologic malignancies.

Thomas W LeBlanc1.   

Abstract

Palliative care specialists have had little involvement in the care of patients with hematologic malignancies. The reasons for this are not clear, because these patients certainly face a significant symptom burden, and many hematologic malignancies are either incurable or carry poor prognoses. For example, acute myeloid leukemia (AML) in patients over age 60 has a 5-year survival of less than 10%, akin to pancreatic cancer. Although most oncologists would agree with involving palliative care specialists in the case of advanced pancreatic cancer, few seem to consider this in the context of AML. Why should AML be any different?

Entities:  

Year:  2014        PMID： 24971402     DOI： 10.12788/jcso.0012

Source DB:  PubMed          Journal:  J Community Support Oncol        ISSN： 2330-7749


  7 in total

Review 1.  Early Palliative Care for Patients with Hematologic Malignancies: Is It Really so Difficult to Achieve?

Authors:  Thomas W LeBlanc; Eric J Roeland; Areej El-Jawahri
Journal:  Curr Hematol Malig Rep       Date:  2017-08       Impact factor: 3.952

2.  System-Level Factors Associated With Use of Outpatient Specialty Palliative Care Among Patients With Advanced Cancer.

Authors:  Justin A Yu; Kristin N Ray; Seo Young Park; Amanda Barry; Cardinale B Smith; Peter G Ellis; Yael Schenker
Journal:  J Oncol Pract       Date:  2018-11-08       Impact factor: 3.840

3.  The Surprise Question and Identification of Palliative Care Needs among Hospitalized Patients with Advanced Hematologic or Solid Malignancies.

Authors:  Kathryn Elizabeth Hudson; Steven Paul Wolf; Gregory P Samsa; Arif H Kamal; Amy Pickar Abernethy; Thomas William LeBlanc
Journal:  J Palliat Med       Date:  2018-02-08       Impact factor: 2.947

4.  Perceptions of palliative care among hematologic malignancy specialists: a mixed-methods study.

Authors:  Thomas W LeBlanc; Jonathan D O'Donnell; Megan Crowley-Matoka; Michael W Rabow; Cardinale B Smith; Douglas B White; Greer A Tiver; Robert M Arnold; Yael Schenker
Journal:  J Oncol Pract       Date:  2015-03       Impact factor: 3.840

Review 5.  Palliative and End-of-Life Care in Myelodysplastic Syndromes.

Authors:  Myles Nickolich; Areej El-Jawahri; Thomas W LeBlanc
Journal:  Curr Hematol Malig Rep       Date:  2016-12       Impact factor: 3.952

6.  Adherence to Measuring What Matters Items When Caring for Patients With Hematologic Malignancies Versus Solid Tumors.

Authors:  Thomas W LeBlanc; Christine S Ritchie; Fred Friedman; Janet Bull; Jean S Kutner; Kimberly S Johnson; Arif H Kamal
Journal:  J Pain Symptom Manage       Date:  2016-11-01       Impact factor: 3.612

7.  Care management by oncology nurses to address palliative care needs: a pilot trial to assess feasibility, acceptability, and perceived effectiveness of the CONNECT intervention.

Authors:  Yael Schenker; Douglas White; Margaret Rosenzweig; Edward Chu; Charity Moore; Peter Ellis; Peggy Nikolajski; Colleen Ford; Greer Tiver; Lauren McCarthy; Robert Arnold
Journal:  J Palliat Med       Date:  2014-12-17       Impact factor: 2.947
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.